Zobrazeno 1 - 10
of 52
pro vyhledávání: '"novel oral anticoagulation"'
Autor:
Woon Hyung Chae, Heinrich Wieneke, Iryna Dykun, Cornelius Deuschl, Martin Köhrmann, Benedikt Frank
Publikováno v:
Case Reports in Neurology, Vol 13, Iss 1, Pp 225-232 (2021)
In patients with atrial fibrillation, catheter ablation is suggested to reduce the mortality rate and is thus frequently performed. However, peri- and postprocedural thromboembolic complications as well as high recurrence rates of atrial fibrillation
Externí odkaz:
https://doaj.org/article/7f889f3ed72b448a8c1c09111ce68a55
Autor:
Xiaoye Li, Xiaochun Zhang, Qinchun Jin, Ying Xue, Wenjing Lu, Junbo Ge, Daxin Zhou, Qianzhou Lv
Publikováno v:
Frontiers in Pharmacology, Vol 12 (2021)
Objective: Due to the clinical complexity of warfarin, novel oral anticoagulation (NOAC) has been a feasible and safe alternative anticoagulant approach during left atrial appendage closure (LAAC). This study was designed to compare the efficacy and
Externí odkaz:
https://doaj.org/article/899014613138426eb7af869d007a7996
Publikováno v:
Frontiers in Pharmacology, Vol 11 (2020)
Percutaneous left atrial appendage closure (LAAC) is an effective and safe operation strategy for stroke prevention in patients who are diagnosed with atrial fibrillation (AF) but cannot tolerate long term anticoagulation medication. We presented fou
Externí odkaz:
https://doaj.org/article/9491bdd8a808476b995b40f29003fb0e
Autor:
Jordan Etscheidt, Amir Shahien, Monique Gainey, Daniel Kronenfeld, Ruijia Niu, David Freccero, Eric Smith
Publikováno v:
Geriatrics, Vol 5, Iss 1, p 18 (2020)
Hip and knee arthroplasty patients are at high risk of perioperative venous thromboembolic events (VTE). VTE has been well studied in this population and it is recommended that total joint arthroplasty recipients receive chemoprophylactic anticoagula
Externí odkaz:
https://doaj.org/article/0dd133bb3beb4ec6a352f86485b31c46
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Martin Köhrmann, Benedikt Frank, Heinrich Wieneke, Iryna Dykun, Woon Hyung Chae, Cornelius Deuschl
Publikováno v:
Case Reports in Neurology
Case Reports in Neurology, Vol 13, Iss 1, Pp 225-232 (2021)
Case Reports in Neurology, Vol 13, Iss 1, Pp 225-232 (2021)
In patients with atrial fibrillation, catheter ablation is suggested to reduce the mortality rate and is thus frequently performed. However, peri- and postprocedural thromboembolic complications as well as high recurrence rates of atrial fibrillation
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cd58136eafc7b117b2fc5d3eda9afdb2
https://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&origin=inward&scp=85105575582
https://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&origin=inward&scp=85105575582
Autor:
Qinchun Jin, Wenjing Lu, Xiaochun Zhang, Xiaoye Li, Junbo Ge, Qianzhou Lv, Ying Xue, Daxin Zhou
Publikováno v:
Frontiers in Pharmacology
Frontiers in Pharmacology, Vol 12 (2021)
Frontiers in Pharmacology, Vol 12 (2021)
Objective: Due to the clinical complexity of warfarin, novel oral anticoagulation (NOAC) has been a feasible and safe alternative anticoagulant approach during left atrial appendage closure (LAAC). This study was designed to compare the efficacy and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e3f9f6ab3dc0ed49fe125ce3a318da75
https://pubmed.ncbi.nlm.nih.gov/34220493
https://pubmed.ncbi.nlm.nih.gov/34220493
Publikováno v:
Frontiers in Pharmacology, Vol 11 (2020)
Percutaneous left atrial appendage closure (LAAC) is an effective and safe operation strategy for stroke prevention in patients who are diagnosed with atrial fibrillation (AF) but cannot tolerate long term anticoagulation medication. We presented fou
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::604f1f0cf1a0f35b799e6b97c3aae82c
https://doi.org/10.3389/fphar.2020.563920
https://doi.org/10.3389/fphar.2020.563920
Autor:
Ruijia Niu, Eric L. Smith, David M. Freccero, Amir Shahien, Jordan Etscheidt, Daniel S Kronenfeld, Monique Gainey
Publikováno v:
Geriatrics, Vol 5, Iss 1, p 18 (2020)
Geriatrics
Geriatrics
Hip and knee arthroplasty patients are at high risk of perioperative venous thromboembolic events (VTE). VTE has been well studied in this population and it is recommended that total joint arthroplasty recipients receive chemoprophylactic anticoagula
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ddac3aa678b3373f7cf4698c52fa0777
https://www.mdpi.com/2308-3417/5/1/18
https://www.mdpi.com/2308-3417/5/1/18
Autor:
Mattie J. Lenzen, Tamas Szili-Torok, Sing-Chien Yap, Christiaan J. Vroegh, John de Heide, Felix Zijlstra, Sip Wijchers, Rohit E Bhagwandien
Publikováno v:
Journal of Interventional Cardiac Electrophysiology
Journal of Interventional Cardiac Electrophysiology, 53(3), 341-346. Springer Netherlands
Journal of Interventional Cardiac Electrophysiology, 53(3), 341-346. Springer Netherlands
Purpose: The safety and efficacy of a minimally interrupted novel oral anticoagulant (NOAC) strategy at the time of atrial fibrillation (AF) ablation is uncertain. The purpose of this study was to compare rates of bleeding and thromboembolic events b
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5a49ec45a7a12f8f9860ae2262f413b5
http://europepmc.org/articles/PMC6292967
http://europepmc.org/articles/PMC6292967